-
NEWS RELEASE
February 4th is World Cancer Day!
2023.01.25
World Cancer Day was established on February 4th, 2000, at the World Summit Against Cancer for the New Millennium in Paris initiated by UICC (Union for International Cancer Control).
-
PUBLICATION
Study on the efficacy of dietary supplements in the mdx mouse published in bioRxiv.
2023.01.19
SMC is proud to announce that GN Corporation (JPN) has published the results of their study using our pre-clinical services in bioRxiv.
-
NEWS RELEASE
SMC announces Announcement of webinar 【High quality non-clinical study designs】
2023.01.11
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place next week on January 19th (JST) from 10:30 AM.
-
NEWS RELEASE
NASH, the fastest growing cause of liver cancer
2023.01.05
We wish you a Happy and Prosperous New Year!
-
UPCOMING EVENTS
SMC to attend Japan-UK Virtual Partnering!
2022.12.28
We are pleased to announce that SMC Laboratories will be participating in the Japan-UK Virtual Partnering Online Event from January 23rd (Mon) to February 13th (Mon).
-
NEWS RELEASE
Fibrosis is involved in many diseases and disease-related deaths
2022.12.20
Today's topic is Fibrosis.
-
PUBLICATION
Study on the efficacy of dietary supplements in the STAM™ model published in Cell Death & Disease.
2022.12.13
SMC is proud to announce that J2H biotech (KOR) has published the results of their study using our pre-clinical services with STAM™ model in Cell Death & Disease.
-
PRODUCTS AND SERVICES
Introduction of STAM™ model for pre-clinical studies for liver cancer
2022.12.05
Today, we give you a brief introduction to our proprietary NASH-HCC model (STAM™ model).
-
PUBLICATION
2022.11.30
SMC is proud to announce that GN Corporation Co. Ltd (JPN) has published the results of their study using our STAM™ model in BMJ Open Gastroenterology.
-
PUBLICATION
Drug Efficacy Study in the STAM™ Model Published in Biomedicines.
2022.11.24
SMC is proud to announce that MRM Health (BEL) has published the results of their study using our STAM™ model in Biomedicines.
-
PRODUCTS AND SERVICES
Introducing our new skin disease model: Imiquimod (IMQ)-induced psoriasis model
2022.11.16
We are pleased to announce that we have expanded our preclinical model lineup by including the "Imiquimod (IMQ)-induced dermatitis model" for psoriasis.
-
NEWS RELEASE
Introduction of MAFLD criteria and the disease model
2022.11.09
Today, we would like to introduce metabolic dysfunction-associated fatty liver disease (MAFLD), a new concept in the study of fatty liver disease.